Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiayue Wang, Bohong Wang & Yan Zhang. (2020) Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ). Journal of Biomolecular Structure and Dynamics 38:2, pages 398-409.
Read now
Read now
Ichiro Takada & Makoto Makishima. (2020) Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present). Expert Opinion on Therapeutic Patents 30:1, pages 1-13.
Read now
Read now
Ichiro Takada & Makoto Makishima. (2015) Therapeutic application of vitamin D receptor ligands: an updated patent review. Expert Opinion on Therapeutic Patents 25:12, pages 1373-1383.
Read now
Read now
Articles from other publishers (10)
Sayuri Takahashi, Ichiro Takada, Kenichi Hashimoto, Atsushi Yokoyama, Tohru Nakagawa, Makoto Makishima & Haruki Kume. (2023) ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1. Scientific Reports 13:1.
Crossref
Crossref
Márcia V. de Carvalho, Cassiano F. Gonçalves-de-Albuquerque & Adriana R. Silva. (2021) PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases. International Journal of Molecular Sciences 22:2, pages 805.
Crossref
Crossref
Liwei Wu, Chuanyong Guo & Jianye Wu. (2020) Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of Cellular and Molecular Medicine 24:5, pages 2736-2748.
Crossref
Crossref
Pengfei Chen, Xiubing Chen, Lei Lei, Yang Zhang, Jianjun Xiang, Jinxia Zhou & Jun Lv. (2020) The efficacy and safety of pioglitazone in psoriasis vulgaris. Medicine 99:32, pages e21549.
Crossref
Crossref
Hoe‐Yune Jung, Bobae Kim, Hye Guk Ryu, Yosep Ji, Soyoung Park, Seung Hee Choi, Dohyun Lee, In‐Kyu Lee, Munki Kim, You Jeong Lee, Woojin Song, Young Hee Lee, Hyung Jin Choi, Chang‐Kee Hyun, Wilhelm H Holzapfel & Kyong‐Tai Kim. (2018) Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice. Diabetes, Obesity and Metabolism 20:7, pages 1688-1701.
Crossref
Crossref
Yifeng Jin, Younho Han, Daulat Bikram Khadka, Chao Zhao, Kwang Youl Lee & Won-Jea Cho. (2016) Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects. Scientific Reports 6:1.
Crossref
Crossref
Luana Amorim Biondo, Edson Alves Lima Junior, Camila Oliveira Souza, Maysa Mariana Cruz, Roberta D. C. Cunha, Maria Isabel Alonso-Vale, Lila Missae Oyama, Claudia M. Oller Nascimento, Gustavo Duarte Pimentel, Ronaldo V. T. dos Santos, Fabio Santos Lira & Jos? Cesar Rosa Neto. (2016) Impact of Doxorubicin Treatment on the Physiological Functions of White Adipose Tissue. PLOS ONE 11:3, pages e0151548.
Crossref
Crossref
Letizia Giampietro, Alessandra Ammazzalorso, Isabella Bruno, Simone Carradori, Barbara De Filippis, Marialuigia Fantacuzzi, Antonella Giancristofaro, Cristina Maccallini & Rosa Amoroso. (2016)
Synthesis of Naphthyl-, Quinolin- and Anthracenyl Analogues of Clofibric Acid as PPAR
α
Agonists
. Chemical Biology & Drug Design 87:3, pages 467-471.
Crossref
Crossref
Sireewan Kaewsuwan, Anuchit Plubrukarn, Maleeruk Utsintong, Seok‑Ho Kim, Jin‑Hyun Jeong, Jin Cho, Sang Park & Jong‑Hyuk Sung. (2016) Interruptin B induces brown adipocyte differentiation and glucose consumption in adipose-derived stem cells. Molecular Medicine Reports.
Crossref
Crossref
Xiao-Rong Peng, Peter Gennemark, Gavin O’Mahony & Stefano Bartesaghi. (2015) Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity. Frontiers in Endocrinology 6.
Crossref
Crossref